Sermon K, Seneca S, De Rycke M, Goossens V, Van de Velde H, De Vos A, Platteau P, Lissens W, Van Steirteghem A, Liebaers I (2001) PGD in the lab for triplet repeat diseases - myotonic dystrophy, Huntington's disease and Fragile-X syndrome. Mol Cell Endocrinol 183 Suppl 1, S77-S71.

De Vos A, Van Steirteghem A (2001) Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat Diagn 21, 767-761.

Georgiou I, Sermon K, Lissens W, De Vos A, Platteau P, Lolis D, Van Steirteghem A, Liebaers I (2001) Preimplantation genetic diagnosis for spinal and bulbar muscular atrophy (SBMA). Hum Genet 108, 494-491.

van Steirteghem A (2001) Twenty years of in vitro fertilization: realization and questions for the future. Verh K Acad Geneeskd Belg 63, 193-192.

Manning M, Lissens W, Liebaers I, Van Steirteghem A, Weidner W (2001) Imprinting analysis in spermatozoa prepared for intracytoplasmic sperm injection (ICSI). Int J Androl 24, 87-81.

De Rycke M, Van de Velde H, Sermon K, Lissens W, De Vos A, Vandervorst M, Vanderfaeillie A, Van Steirteghem A, Liebaers I (2001) Preimplantation genetic diagnosis for sickle-cell anemia and for beta-thalassemia. Prenat Diagn 21, 214-211.

Tavaniotou A, Smitz J, Bourgain C, Devroey P (2001) Ovulation induction disrupts luteal phase function. Ann N Y Acad Sci 943, 55-51.

Albano C, Platteau P, Nogueira D, Cortvrindt R, Smitz J, Devroey P (2001) Avoidance of multiple pregnancies after ovulation induction by supernumerary preovulatory follicular reduction. Fertil Steril 76, 820-821.

Olivennes F, Mannaerts B, Struijs M, Bonduelle M, Devroey P (2001) Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report. Hum Reprod 16, 1588-1581.

Shenfield F, Pennings G, Sureau C, Cohen J, Devroey P, Tarlatzis B (2001) I. The moral status of the pre-implantation embryo. Hum Reprod 16, 1046-1041.

Albano C, Platteau P, Devroey P (2001) Gonadotropin-releasing hormone antagonist: how good is the new hope? Curr Opin Obstet Gynecol 13, 257-251.

Diedrich K, Frydman R, Devroey P, Felberbaum R, Schally AV, Reissmann T, Engel J (2001) Comment on the debate article: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod 16, 1305-1301.

Smitz J, Nogueira D, Albano C, Cortvrindt R, Devroey P (2001) Improving in vitro maturation of oocytes in the human taking lessons from experiences in animal species. Reprod Domest Anim 36, 11-11.

Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P (2001) Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 7, 161-161.

Tavaniotou A, Albano C, Smitz J, Devroey P (2001) Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix. Hum Reprod 16, 663-661.

Ludwig M, Riethmuller-Winzen H, Felberbaum RE, Olivennes F, Albano C, Devroey P, Diedrich K (2001) Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix. Fertil Steril 75, 18-11.

Van Landuyt L, Lissens W, Stouffs K, Tournaye H, Van Steirteghem A, Liebaers I, Blagosklonova O, Bresson JL (2001) The role of USP9Y and DBY in infertile patients with severely impaired spermatogenesis. Mol Hum Reprod 7, 691-691.

Stouffs K, Lissens W, Van Landuyt L, Tournaye H, Van Steirteghem A, Liebaers I (2001) Characterization of the genomic organization, localization and expression of four PRY genes (PRY1, PRY2, PRY3 and PRY4). Mol Hum Reprod 7, 603-601.